Related Experiment Video
Updated: Sep 3, 2025
12:55
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.5K
Neoantigen-Specific T Cells in Adoptive Cell Therapy
1From the Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR.
Cancer Journal (Sudbury, Mass.)
|July 26, 2022
Summary
Targeting cancer neoantigens with adoptive cell therapy offers a promising strategy for destroying tumor cells while sparing normal tissues. This approach leverages unique mutations for specific immune recognition in epithelial cancers.
Area of Science:
- Oncology
- Immunology
- Cancer Therapeutics
Background:
- Cancer cells possess unique somatic mutations distinguishing them from normal tissues.
- Nonsynonymous mutations can generate mutated peptide antigens, known as neoantigens.
- Neoantigens are specifically recognized by T cells, forming the basis for targeted therapies.
Purpose of the Study:
- To review the clinical application of adoptive cell therapy (ACT) targeting neoantigens.
- To highlight the potential of neoantigen-based immunotherapy in treating epithelial cancers.
Main Methods:
- Review of existing clinical studies and literature on neoantigen-targeted ACT.
- Focus on strategies for identifying and targeting neoantigens in epithelial cancers.
Main Results:
- Neoantigen-specific T cell recognition offers a potential pathway for selective cancer cell destruction.
- Adoptive cell therapy targeting neoantigens shows promise as a safe and effective cancer treatment strategy.
Conclusions:
- Immunological targeting of neoantigens is a safe and promising strategy for cancer treatment.
- Clinical application of neoantigen-targeted adoptive cell therapy is being explored for epithelial cancers.
Related Concept Videos
01:27Tumor Immunotherapy
652
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
652
01:40Cell-mediated Immune Responses
71.0K
Overview
71.0K
01:22T Cell Activation and Clonal Selection
3.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
3.7K
01:27Cytotoxic T Cells-mediated Immune Response
1.2K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.2K
01:24T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
01:20Special Features of Adaptive Immunity
1.1K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
1.1K